12 | Cobra Venture Corporation Q3 2022 Financial | ChadPimm | 10/19/2022 9:40:47 PM |
11 | https://www.youtube.com/watch?v=Eo2hbFFyrWQ | ChadPimm | 10/02/2022 10:06:44 PM |
10 | Cobra Ventures will be announcing their third | ChadPimm | 10/01/2022 9:36:58 PM |
9 | Cobra Venture Corporation Q1 2022 Financial | ChadPimm | 07/14/2022 9:22:34 AM |
8 | Just to confirm the most recent MD&A, Cobra | ChadPimm | 05/07/2022 10:56:32 AM |
7 | Cobra Venture Corporation Q1 2022 Financial | ChadPimm | 04/22/2022 8:52:10 AM |
6 | I think the Q1 numbers for Cobra are going to be | ChadPimm | 04/09/2022 7:10:35 PM |
5 | Cobra Venture Due Diligence Report - Information | ChadPimm | 04/02/2022 1:42:03 PM |
4 | Cobra Venture to pay three-cent special dividend | ChadPimm | 03/23/2022 9:25:24 PM |
3 | Latest Cobra Venture Corp (CBVTF) Headlines Cobra | Stock_Tracker | 03/09/2014 6:06:50 AM |
2 | CBVTF 0.1907 Stock Charts $CBVTF 1 Month Chart | chartguy89 | 03/06/2014 7:33:48 AM |
1 | CBVTF Stock Charts Monday, February 24, 2014 at | chartguy89 | 02/24/2014 6:27:55 AM |
Recent Articles
- Opportunity for Wolfspeed Investors to Pursue Class Action
- Kyverna Therapeutics Investors Alert Over Recent Class Action
- Marqeta Inc. SEC Class Action Lawsuit: What Investors Need to Know
- Urgent Alert for Symbotic Investors Regarding Class Action
- Investors Reminded of Key Deadline in PACS Group Lawsuits
- Crucial Update for Five9 Investors: Lawsuit Deadline Approaching
- Important Update for Rentokil Investors on Class Action Lawsuit
- Important Update for Match Group Investors: Legal Actions Ahead
- Investors Urged to Act in Zeta Global Class Action Case
- Celsius Holdings Investors: Important Litigation Updates
- ASML Holding Class Action: Important Update for Investors
- Deadline Approaches for Hasbro Shareholders in Class Action
- Critical Update for Toronto-Dominion Bank Investors in Class Action
- Investors of Kyverna Therapeutics Can Pursue Class Action
- Xi Jinping Supports Hong Kong's Economic Strategies and Development
- Solar Alliance Energy Gains Shareholder Approval in Key Meeting
- Fruit Street Health Enhances Diabetes Prevention with Meals
- CNOOC Limited Partners with INEOS Energy in New Agreement
- Exciting Collaboration: Celebrate Japan's Fruit Culture
- Investors Urged to Act Before Deadline in Xiao-I Class Action
- Karma Sauce Applauds First We Feast's Bold New Direction
- Cassava Sciences Investors Encouraged to Act on Stock Losses
- Investors Warned of Upcoming Deadline in WM Technology Case
- Investors Urged to Act: Acadia Healthcare Class Action Deadline
- Aehr Test Systems Faces Class Action, Investors Urged to Act Soon
- Investors Alert: Upcoming Lead Plaintiff Motion Deadline for CUBI
- Legal Action Announced for Five9, Inc. Investors Following Stock Decline
- Legal Action Launched for Kyverna Therapeutics Investors
- Everlight Solar's Culture: A Testament to Team Camaraderie and Growth
- Haloid Enhances Safety in Film Productions with Reviews
- Insights on the Growing Demand for Edible Coatings in Produce
- Prospect Ridge Resources Adjusts Plans for Upcoming Meeting
- Legal Update: Toronto-Dominion Bank Securities Class Action
- Key Updates from Nasdaq on the Nasdaq-100 Index Changes
- TeraBox Revolutionizes File Sharing with Free Unlimited Service
- Kessler Topaz Takes Action Against Enphase Energy for Fraud
- Demesne Resources Completes Second Tranche of Financing
- Spiro Celebrated as One of the Top Agencies in Marketing
- Global Uranium Corp. Launches Strategic Marketing Efforts
- UnitedHealth Group Clarifies Misconceptions and Updates Claims
- Neurocrine Biosciences Unveils Potential of CRENESSITY™ for CAH
- Acadia Healthcare Investors Urged to Take Action on Lawsuit
- Global Uranium Corp. Unveils C$1.5 Million Flow-Through Offering
- Rakovina Therapeutics Secures $3M to Propel Cancer Therapy Advances
- Hola Prime's Innovative Vision: New Marketing Director Appointed
- Teamsters Advocate for Stronger Standards on Autonomous Vehicles
- BioVaxys Secures Funding and Enters Debt Settlement Agreement
- Exciting Advancement as UNLOXCYT Gains FDA Approval for Treatment
- OFS Credit Company Shares November Net Asset Value Insights
- New FDA Approval for Crenessity Enhances CAH Treatment Options